UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Boston Scientific Corporation

In a report published Wednesday, Jefferies reiterated its Hold rating on Boston Scientific Corporation

, and raised its price target from $6.00 to $7.60. Jefferies noted, “BSX posted another negative quarter as soft results in CRM and DES resulted in the company posting -1% revenue growth. While stabilization in these two franchises, comprising over half of revenues, remains elusive, the company believes 2013 is when growth tacks back into positive territory. Maintain Hold.” Boston Scientific Corporation closed on Tuesday at $6.86.